Gene · 5337
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARFs get the BioID treatment: what have we been missing? | EMBO J | 2022 | 35929178 | PubTator, text mining | PubMed |
| Breaking the Iron Homeostasis: A "Trojan Horse" Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition. | ACS Nano | 2022 | 35920396 | PubTator, text mining | PubMed |
| Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis. | Genet Res (Camb) | 2022 | 35919036 | PubTator, text mining | PubMed |
| Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review. | Front Aging Neurosci | 2022 | 35912090 | PubTator, text mining | PubMed |
| Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders. | J Neuroinflammation | 2022 | 35897073 | PubTator, text mining | PubMed |
| Characterization of plasma exosomal microRNAs in responding to radiotherapy of human esophageal squamous cell carcinoma. | Mol Med Rep | 2022 | 35894132 | PubTator, text mining | PubMed |
| A Timing-Based Split-Path Sensing Circuit for STT-MRAM. | Micromachines (Basel) | 2022 | 35888821 | PubTator, text mining | PubMed |
| Characterization of Plocamium telfairiae Extract-Functionalized Au Nanostructures and Their Anti-Adipogenic Activity through PLD1. | Mar Drugs | 2022 | 35877714 | PubTator, text mining | PubMed |
RNA Sequencing Reveals the Expression Profiles of circRNAs and Indicates Hsa_circ_0070562 as a Pro-osteogenic Factor in Bone Marrow-Derived Mesenchymal Stem Cells of Patients With Ankylosing Spondylitis. | Front Genet | 2022 | 35873481 | PubTator, text mining | PubMed |
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. | Breast Cancer Res | 2022 | 35850772 | PubTator, text mining | PubMed |
| Brain Somatic Variant in Ras-Like Small GTPase RALA Causes Focal Cortical Dysplasia Type II. | Front Behav Neurosci | 2022 | 35846790 | PubTator, text mining | PubMed |
| Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB. | EMBO J | 2022 | 35844135 | PubTator, text mining | PubMed |
| Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR. | Cell Death Dis | 2022 | 35831271 | PubTator, text mining | PubMed |
| Trends in insulin resistance: insights into mechanisms and therapeutic strategy. | Signal Transduct Target Ther | 2022 | 35794109 | PubTator, text mining | PubMed |
| Glioblastoma: Current Status, Emerging Targets, and Recent Advances. | J Med Chem | 2022 | 35786935 | PubTator, text mining | PubMed |
| Network-Based Analysis Reveals Novel Biomarkers in Peripheral Blood of Patients With Preeclampsia. | Front Mol Biosci | 2022 | 35782866 | PubTator, text mining | PubMed |
| Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway. | J Cell Mol Med | 2022 | 35775110 | PubTator, text mining | PubMed |
| MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription. | Aging (Albany NY) | 2022 | 35771155 | PubTator, text mining | PubMed |
| Effects and associated transcriptomic landscape changes of methamphetamine on immune cells. | BMC Med Genomics | 2022 | 35765053 | PubTator, text mining | PubMed |
| Differential expression patterns of phospholipase D isoforms 1 and 2 in the mammalian brain and retina. | J Lipid Res | 2022 | 35764123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5337/papers?page=12